Figure 5: Models for regulation by AMPK/SNF1 of glucose uptake in muscle and gene expression in yeast. Figure 6: The opposing effects of insulin and AMPK activation on the target-of-rapamycin (TOR ...

Diabetes affects millions worldwide, often triggering complications such as insulin resistance and fatty liver disease. To ...

Type 2 diabetes mellitus (T2DM) is a prevalent yet complex metabolic disorder that has shown a rising incidence over the past few decades. Recent research has identified flavonoids as compounds ...

“Importantly, both fatty15 and rapamycin demonstrated anti-inflammatory, antioxidant, antifibrotic, anticancer and antimicrobial activities, all of which are expected to help extend our healthspan and ...

With the discovery of insulin at the University of Toronto in the early 1920’s, followed by the establishment of commercial production, diabetes was no longer a death sentence. Insulin was not a cure, ...

New research identifies the liver protein PTPRD as a key regulator of metabolic liver disease. Reduced levels of PTPRD disrupt glucose and lipid metabolism, promote liver fat accumulation, and impair ...

How the combination of HIIT with intermittent fasting or a low-calorie diet improves metabolic health among postmenopausal ...

ActivAMP is special because it kicks the body’s natural AMPK into high gear so energy (aka fat) is used more efficiently. It also improves insulin sensitivity and metabolic function.